OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
Single-use equipment, analytics, and automation may add complexity, but they are reducing scale-up costs and timelines.
Joerg Ahlgrimm has left Lonza and is now leading The Discovery Labs’ mission to establish a powerhouse for cell and gene therapy development and manufacturing in the Philadelphia area.
Tufts research suggests costs to launch a new drug have doubled since 2003, but some question conclusions.